Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T16:38:47.319Z Has data issue: false hasContentIssue false
  • English
  • Français

Genetically determined organ specific responses to the teratogenic action of 6-aminonicotinamide in the mouse†

Published online by Cambridge University Press:  14 April 2009

Marc Goldstein ,
Merrille Feiner Pinsky  and
F. C. Fraser
Marc Goldstein
Affiliation:
Department of Genetics, McGill University, Montreal, Canada
Merrille Feiner Pinsky
Affiliation:
Department of Genetics, McGill University, Montreal, Canada
F. C. Fraser
Affiliation:
Department of Genetics, McGill University, Montreal, Canada
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. A two-hour relative deficiency of nicotinamide, produced by maternal treatment with 6-aminonicotinamide, resulted in a maximum frequency of vertebral fusions following treatment on day 9·5 of gestation, and a maximum frequency of cleft palates following treatment on day 13·5.

2. Both defects appeared with higher frequencies in the A/Jax than in the C57BL/6J inbred strain.

3. The frequency of induced vertebral fusions in F1 embryos from crosses between the strains was higher when the father was from the A/Jax strain than when the mother was—a patroclinous reciprocal cross difference.

4. The frequency of induced cleft palate in F1 embryos from crosses between the strains was higher when the mother was from the A/Jax strain than when the father was—a matroclinous reciprocal cross difference.

5. Since the reciprocal cross differences in frequency of vertebral fusions and for cleft palates were in opposite directions, the hereditary factors influencing susceptibility to the teratogen appear to differ for the respective organ anlage. These differences appear to be, in part, cytoplasmic.

6. The frequency of induced cleft palate in the offspring of backcrosses of (untreated) F1 female hybrids to A/Jax males differed according to the cytoplasmic origin of the F1 mothers. Thus the susceptibility of an embryo to the teratogen appears to be influenced by factors transmitted through the cytoplasm.

Type
Research Article
Information
Genetics Research , Volume 4 , Issue 2 , July 1963 , pp. 258 - 265
Copyright
Copyright © Cambridge University Press 1963

References

REFERENCES

Dagg, C. P. & Karnofsky, D. A. (1958). Some effects of 6-aminonicotinamide in chick embryos. Fed. Proc. 17, 361.Google Scholar
Dawson, A. B. (1926). A note on the staining of the skeleton of cleared specimens with alizarinred S. Stain Tech. 1, 123–124.CrossRefGoogle Scholar
Dietrich, L. S., Friedland, I. M. & Kaplan, L. A. (1958). Pyridine nucleotide metabolism: mechanism of action of the niacin antagonist, 6-aminonicotinamide. J. biol. Chem. 233, 964–968.CrossRefGoogle ScholarPubMed
Fraser, F. C. (1963). Methodology of experimental mammalian teratology. Methodology in Mammalian Genetics, Burdette, W. J., Ed. Holden-Day Inc.Google Scholar
Green, E. L. & Green, M. C. (1959). Transplantation of ova in mice. An attempt to modify the number of presacral vertebrae. J. Hered. 50, 109–114.CrossRefGoogle Scholar
Johnson, W. J. & McColl, J. D. (1955). 6-aminonicotinamide—a potent nicotinamide antagonist. Science, 122, 834.CrossRefGoogle ScholarPubMed
Johnson, W. J. & McColl, J. D. (1956). Antimetabolite activity of 6-aminonicotinamide. Fed. Proc. 15, 284.Google Scholar
Kalter, H. (1954). The inheritance of susceptibility to the teratogenic action of cortisone in mice. Genetics, 39, 185–196.CrossRefGoogle Scholar
Kalter, H. & Warkany, J. (1957). Congenital malformations in inbred strains of mice induced by riboflavin deficient, galactoflavin containing diets. J. exp. Zool. 136, 531–566.CrossRefGoogle ScholarPubMed
Kalter, H. & Warkany, J. (1959). Experimental production of congenital malformations in mammals by metabolic procedures. Physiol. Rev. 39, 69–115.CrossRefGoogle Scholar
Landauer, W. (1957). Niacin antagonists and chick development. J. exp. Zool. 136, 509–530.CrossRefGoogle ScholarPubMed
Murphy, M. L., Dagg, C. P. & Karnofsky, D. A. (1957). Comparison of teratogenic chemicals in the rat and chick embryos. Pediatrics, 19, 701–714.CrossRefGoogle ScholarPubMed
Pinsky, L. & Fraser, F. C. (1959). Production of skeletal malformations in the offspring of pregnant mice treated with 6-aminonicotinamide. Biol. Neonat. 1, 106–112.CrossRefGoogle ScholarPubMed
Pinsky, L. & Fraser, F. C. (1960). Congenital malformations following a two-hour inactivation of nicotinamide by its analogue, 6-aminonicotinamide, in pregnant mice. Brit. med. J. 2, 195–197.CrossRefGoogle Scholar
Trasler, D. G. & Fraser, F. C. (1958). Factors underlying strain, reciprocal cross, and maternal weight differences in embryo susceptibility to cortisone-induced cleft palate in mice. Proc. X Int. Cong. Genet. 2, 296–297.Google Scholar
Walker, B. E. (1954). Genetico-embryological studies in normal and cleft palates in mice. Ph.D. Thesis (McGill University).Google Scholar